FDA Warns Soon-Shiong Over Anktiva Cancer Drug Claims
Irvine News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Federal health officials issue warning to biotech billionaire Dr. Patrick Soon-Shiong over exaggerated claims about his companys bladder cancer drug, Anktiva. The drug, approved for a tough-to-treat bladder cancer, is now under scrutiny for promotions suggesting it could treat, cure, or prevent other cancers like lung and pancreatic types. Shares in ImmunityBio plummeted after the warning, and the company plans to cooperate with the FDA. This case highlights strict rules around promoting unapproved benefits and the tougher enforcement on drug ads, including those on podcasts and TV shows.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/ee2cd1d96efa62f4